Cyclin C antibody
Quick Overview for Cyclin C antibody (ABIN7228118)
Target
See all Cyclin C (CCNC) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Rabbit Anti-Cyclin C Polyclonal Antibody
-
Specificity
- This antibody detects endogenous levels of Cyclin C.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human Cyclin C protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:10000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- Cyclin C (CCNC)
-
Alternative Name
- Cyclin C
-
Background
- Cyclin-C, SRB11 homolog, hSRB11CCNC (Cyclin C) is a Protein Coding gene. Among its related pathways are Signaling by NOTCH1 and Metabolism. The protein encoded by CCNC is a member of the cyclin family of proteins. The encoded protein interacts with cyclin-dependent kinase 8 and induces the phophorylation of the carboxy-terminal domain of the large subunit of RNA polymerase II. The level of mRNAs for CCNC peaks in the G1 phase of the cell cycle. Two transcript variants encoding different isoforms have been found for CCNC.
-
Molecular Weight
- 33-37kD
-
Gene ID
- 892
-
UniProt
- P24863
-
Pathways
- Cell Division Cycle, Regulation of Lipid Metabolism by PPARalpha
Target
-